TRL1068 clinical trials
How each study uses TRL1068 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the TRL1068 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2021 (1)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
Who runs them
Industry 3 · Other 0
Trellis Bioscience LLC (3)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test TRL1068.
- Dec 2026Study to Evaluate Safety and Activity of Inhaled TRL1068 in Healthy VolunteersPhase 1 · Trellis Bioscience LLC
Studies
Open first, then newest update. How each study uses TRL1068 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Study to Evaluate Safety and Activity of Inhaled TRL1068 in Healthy VolunteersNot yet recruitingPhase 1Trellis Bioscience LLCNCT07644195Written as TRL1068, a human monoclonal antibody
- Study to Evaluate Safety and Activity of TRL1068 in Prosthetic Joint InfectionsCompletedPhase 1Trellis Bioscience LLCNCT04763759Written as TRL1068, a human monoclonal antibody
- Study to Evaluate Safety and Activity of TRL1068 in Chronic RhinosinusitisStatus unknownPhase 1Trellis Bioscience LLCNCT05355207Written as TRL1068